Home > Compound List > Product Information
BN82002 hydrochloride_Molecular_structure_CAS_396073-89-5)
Click picture or here to close

BN82002 hydrochloride

Catalog No. B1061 Name Sigma Aldrich
CAS Number 396073-89-5 Website http://www.sigmaaldrich.com
M. F. C19H26ClN3O4 Telephone 1-800-521-8956
M. W. 395.88044 Fax
Purity ≥97% (HPLC) Email
Storage Chembase ID: 153107

SYNONYMS

IUPAC name
4-(dimethylamino)-2-methoxy-6-({methyl[2-(4-nitrophenyl)ethyl]amino}methyl)phenol hydrochloride
IUPAC Traditional name
4-(dimethylamino)-2-methoxy-6-({methyl[2-(4-nitrophenyl)ethyl]amino}methyl)phenol hydrochloride
Synonyms
4-Dimethylamino-2-methoxy-6-((methyl-[2-(4-nitrophenyl)ethyl]amino)methyl)phenol

DATABASE IDS

PubChem SID 24724410
CAS Number 396073-89-5
MDL Number MFCD08276984

PROPERTIES

Empirical Formula (Hill Notation) C19H25N3O4 · xHCl
Purity ≥97% (HPLC)
Apperance tan solid
Solubility DMSO: soluble10 mg/mL
MSDS Link Download
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Caution
Hygroscopic.
Biochem/physiol Actions
BN82002 is a potent, selective, and irreversible CDC25 phosphatase family inhibitor. BN82002 displays ~20-fold greater selectivity over CD45 tyrosine phosphatase (IC50 in μM = 2.4, 3.9, 6.3, 5.4, and 4.6 for 25A, 25B2, 25B3, 25C, and 25C-cat, respectively). BN82002 has been shown to delay cell cycle progression in vitro (IC50 in the range of 7.2 - 32.6 μM). BN82002 reduces tumor growth in athymic mice xenografted with the human pancreatic cell MIA PaCa-2 (15 mg/kg, i.p. route).
Description (简体中文)
Caution
Hygroscopic.
Biochem/physiol Actions
BN82002 is a potent, selective, and irreversible CDC25 phosphatase family inhibitor. BN82002 displays ~20-fold greater selectivity over CD45 tyrosine phosphatase (IC50 in μM = 2.4, 3.9, 6.3, 5.4, and 4.6 for 25A, 25B2, 25B3, 25C, and 25C-cat, respectively). BN82002 has been shown to delay cell cycle progression in vitro (IC50 in the range of 7.2 - 32.6 μM). BN82002 reduces tumor growth in athymic mice xenografted with the human pancreatic cell MIA PaCa-2 (15 mg/kg, i.p. route).

REFERENCES